arrow
A

Anish Thomas

national institutes of health
H指数:55
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SCLC TumorMiner: A genomics platform for small cell lung cancer precision oncology

SCLC TumorMiner:一种用于小细胞肺癌精准肿瘤学的基因组学平台

2026-09-030
OAAI
A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250)

II期、多中心、开放标签、单臂研究:伯佐塞替联合拓扑替康治疗复发铂耐药小细胞肺癌患者(DDRiver SCLC 250)

2025-12-010
OAAI
A genome-wide RNAi screen for novel CIN genes using human artificial chromosome

利用人工染色体的全基因组RNAi筛选新型染色体不稳定性(CIN)基因

2025-12-010
OAAI
Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling

针对晚期实体瘤的肿瘤靶向拓扑异构酶i抑制剂递送与优化PARP抑制:一种间隔给药方案的i期临床试验

2025-10-270
OAAI
Basal cell of origin resolves neuroendocrine–tuft lineage plasticity in cancer

起源的基底细胞解决了癌症中神经内分泌-簇细胞谱系的可塑性

Nature
IF48.5
2025-09-170
OA
Metastatic Organotropism in Small Cell Lung Cancer

小细胞肺癌的转移性器官趋向性

2025-08-290
PRE
Advances in Lung Cancer Basic and Translational Research in 2025 – Overview and Perspectives Focusing on NSCLC

2025年肺癌基础与转化研究进展——聚焦NSCLC的概述与展望

2025-06-030
PRE
Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor

循环游离DNA和匹配的转移性肿瘤中的基因组改变和转录组表型

2025-02-250
OA
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
2024-09-271
OAAI
Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities
2024-06-014
OAAI
Hyperprogressive disease following bintrafusp alfa and DNA damaging chemotherapy in relapsed small cell lung cancer
2024-04-050
PRE
CDK-independent role of D-type cyclins in regulating DNA mismatch repair
2024-04-012
OAAI